Ani Pharmaceuticals Inc financial data

Symbol
ANIP on Nasdaq
Location
210 Main Street West, Baudette, MN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 266 % -29.9%
Quick Ratio 68.2 % -17%
Debt-to-equity 207 % +108%
Return On Equity -2.45 % -140%
Return On Assets -0.78 % -126%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 1.2B USD +45.6%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 19.8M shares +2.66%
Weighted Average Number of Shares Outstanding, Diluted 20.3M shares +5.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 747M USD +38.7%
Research and Development Expense 53.9M USD +38.9%
Costs and Expenses 732M USD +49.8%
Operating Income (Loss) 15.2M USD -69.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.7M USD -142%
Income Tax Expense (Benefit) -4.54M USD -153%
Net Income (Loss) Attributable to Parent -10.2M USD -138%
Earnings Per Share, Basic 0 USD/shares -156%
Earnings Per Share, Diluted 0 USD/shares -157%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 218M USD -9.29%
Accounts Receivable, after Allowance for Credit Loss, Current 226M USD +35.9%
Inventory, Net 138M USD +10.3%
Assets, Current 603M USD +8.49%
Deferred Income Tax Assets, Net 92M USD +2.81%
Property, Plant and Equipment, Net 59.2M USD +14.7%
Intangible Assets, Net (Excluding Goodwill) 520M USD +184%
Goodwill 60.5M USD +114%
Other Assets, Noncurrent 8.25M USD -35.8%
Assets 1.34B USD +45.9%
Accounts Payable, Current 54.6M USD +12.1%
Employee-related Liabilities, Current 32.9M USD +104%
Accrued Liabilities, Current 14.8M USD +113%
Contract with Customer, Liability, Current 5M USD
Liabilities, Current 237M USD +69.2%
Operating Lease, Liability, Noncurrent 4.39M USD +6.86%
Other Liabilities, Noncurrent 6.7M USD +43.1%
Liabilities 881M USD +100%
Accumulated Other Comprehensive Income (Loss), Net of Tax 3.31M USD -60.2%
Retained Earnings (Accumulated Deficit) -76.9M USD -18.2%
Stockholders' Equity Attributable to Parent 437M USD -4.17%
Liabilities and Equity 1.34B USD +45.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 35M USD +91.5%
Net Cash Provided by (Used in) Financing Activities -9.91M USD +49.8%
Net Cash Provided by (Used in) Investing Activities -19.8M USD -322%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.94M USD -33.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 218M USD -9.28%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.9M USD +11.9%
Deferred Tax Assets, Valuation Allowance 9.5M USD +2275%
Deferred Tax Assets, Gross 121M USD +18.1%
Operating Lease, Liability 6.19M USD +9.17%
Payments to Acquire Property, Plant, and Equipment 2.47M USD -46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.2M USD -170%
Lessee, Operating Lease, Liability, to be Paid 7.21M USD +8.29%
Property, Plant and Equipment, Gross 77.5M USD +2.07%
Operating Lease, Liability, Current 1.8M USD +15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.78M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.08M USD +5.95%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.02M USD +3.23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.79M USD +39%
Deferred Tax Assets, Operating Loss Carryforwards 27.3M USD +840%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.67M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.02M USD -20.6%
Additional Paid in Capital 542M USD +1.77%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 76.1M USD +44.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%